:max_bytes(150000):strip_icc()/GettyImages-2173745287-f46663dfbd3c433283d78f330c4399f4.jpg)
Cal-Maine Foods (CALM) significantly surpassed Q4 FY25 earnings and revenue estimates, reporting EPS of $7.04 and revenue of $1.10 billion, a 72.2% increase. This robust performance was primarily driven by a 54.9% surge in average egg selling prices to $3.31 and higher sales volumes, attributed to industry-wide shell egg shortages caused by highly pathogenic avian influenza outbreaks coinciding with strong Easter holiday demand. Consequently, CALM shares traded at an all-time high, rising over 15% in morning trading.
Cal-Maine Foods (CALM) delivered a significant outperformance in its fourth-quarter fiscal 2025 results, decisively beating analyst consensus on both revenue and earnings. The company reported earnings of $7.04 per share, surpassing the $6.28 estimate, while revenue surged 72.2% year-over-year to $1.10 billion. This robust performance was primarily driven by an acute supply-demand imbalance in the egg market. A 54.9% jump in the average egg selling price to $3.31 per dozen was a direct consequence of industry-wide supply shortages caused by highly pathogenic avian influenza (HPAI), which coincided with peak seasonal demand around the Easter holiday. Notably, Cal-Maine also demonstrated operational strength by increasing its sales volume to 311.4 million dozen from 285.6 million in the prior year, attributing this growth to both organic and inorganic expansion. The market reacted with pronounced bullishness, sending the stock up over 15% to an all-time high, reflecting the company's ability to capitalize on these highly favorable, albeit externally driven, market conditions.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
extremely positive
Sentiment Score
0.90
Ticker Sentiment